http://purl.org/np/RAa5ZPrqWn... RAa5ZPrqWn

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-11T07:30:52.676Z

http://purl.org/np/RAa5ZPrqWn... RAa5ZPrqWn

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-11T07:30:52.676958

Elif Ozkan

2022-10-11T07:30:52.676Z

http://purl.org/np/RAa5ZPrqWn... RAa5ZPrqWn

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Lovastatin tablets USP should be used in addition to a diet restricted in saturated fat and cholesterol as part of a treatment strategy to lower total-C and LDL-C to target levels when the response to diet and other nonpharmacological measures alone has been inadequate to reduce risk. The tablets are indicated to reduce the risk of:: Myocardial infarction-Unstable angina; Coronary revascularization procedures.

Elif Ozkan

2022-10-11T07:30:52.676Z